News Bio Vitos Pharma AB

Equities

BIOVIT

SE0009320278

Market Closed - Nasdaq Stockholm Other stock markets 03:39:54 2024-05-03 am EDT			5-day change	1st Jan Change
0.1785 ^SEK	+0.85%		-7.99%	-25.00%

Feb. 14	Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 14	Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 14	CI
Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 14	CI
Bio Vitos Pharma Teams Up with KFUM Kalmar to Explore Benefits of Iron Succinate for Female Athletes	Feb. 12	MT
KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer	Feb. 12	AQ
KFUM Kalmar and Bio Vitos Pharma Sign Collaboration Agreement to Conduct Research Study on Succifer	Feb. 12	CI
The European Patent Office EPO grants patent that is important to Bio Vitos Pharma	Dec. 20	AQ
The European Patent Office EPO Grants Patent to Bio Vitos Pharma AB	Dec. 20	CI
Hemcheck Sweden AB will Change its Ticker to BIOVIT from HEMC	Dec. 06	CI
Hemcheck Sweden AB will Change its Name to Bio Vitos Pharma AB	Dec. 06	CI
Hemcheck Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 16	CI
Hemcheck completes the transaction with Bio Vitos	23-10-20	AQ
Hemcheck Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-30	CI
Hemcheck has received a first order from its distributor Astemed	23-05-15	AQ
Hemcheck Sweden AB Receives A First Order from Its Distributor Astemed	23-05-15	CI
Hemcheck Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement	23-05-04	AQ
Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)	23-04-26	AQ
Hemcheck Sweden Receives New Follow Up Order from the Foundation for Innovative New Diagnostics	23-04-26	CI
Hemcheck has received a first order from the university hospital Charité in Berlin	23-04-05	AQ
Hemcheck Sweden AB Receives First Order from the University Hospital Charité in Berlin	23-04-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bio Vitos Pharma AB

Equities

BIOVIT

SE0009320278

Summary

Filters